EP3756652
STÖÐUGAR EFNABLÖNDUR MEÐ AND-INTERLEUKIN-6-VIÐTAKA (IL-6R) MÓTEFNI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.1.2011EP published:
22.6.2022EP application number:
20184418.0
EP translation filed:
1.9.2022Grant published:
15.11.2022EPO information:
European Patent Register
Max expiry date:
6.1.2031Expiry date:
6.1.2027Next due date:
31.1.2027
Title in English:
STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) ANTIBODIESLanguage of the patent:
English
Timeline
Today
7.1.2011EP application
22.6.2022EP Publication
1.9.2022Translation submitted
15.11.2022Registration published
6.1.2027Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
Inventor
Name:
DIX, Daniel, BAddress:
LaGrangeville, NY 12540, US
Name:
GRAHAM, Kenneth, S.Address:
Pleasant Valley, NY 12569, US
Name:
KAMEN, Douglas, E.Address:
Poughquag, NY 12570, US
Name:
WALSH, Scott, M.Address:
Tarrytown, NY 10591, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
29322710 PDate:
8.1.2010Country:
US
Classification
Categories:
A61K 9/00, A61K 9/08, A61K 31/485, A61K 39/395, A61K 47/18, A61K 47/26, A61P 19/00, A61P 19/02, A61P 25/00, A61P 29/00, A61P 37/02, A61P 37/06, C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 22.12.2022
Expires: 6.1.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 20.12.2023
Expires: 6.1.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 27.12.2024
Expires: 6.1.2026
Payer: Árnason Faktor ehf.
Number: 16
Paid: 7.1.2026
Expires: 6.1.2027
Payer: Árnason Faktor ehf.